Company / Interest Expense
IRONWOOD PHARMACEUTICALS INC Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$21.6M
FY2023
5-year range
$21.6M / $31.1M
FY2019-FY2023
Trend
-26.6%
vs FY2022
Sector context
#18 of 44
Health Care
What the data says
At $22M, IRONWOOD PHARMACEUTICALS INC's interest expense ranks #27 of 44 in the Health Care sector. Interest Expense has declined for 3 consecutive years, from $38M in FY2020 to $22M in FY2023.
Based on SEC 10-K filings.
$22M in FY2023 with a 5-year CAGR of -11.2%.
Improved from $31M to $22M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -16.9%
- 5-Year CAGR
- -11.2%
- 10-Year CAGR
- -
Sector benchmark
#27 of 44 in Health CareTop 59% of 44This company $21.6M Sector average $291.0M
▼
-92.6% below sector average
Key checks
Key Insights
- IRONWOOD PHARMACEUTICALS INC's interest expense has declined for 3 consecutive years.
- 5-year CAGR of -11.2%, indicating a declining trend.
- In FY2023, interest expense decreased 26.6% year-over-year.
- Ranks #18 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $21.6M | -26.6% |
| FY2022 | $29.5M | -5.4% |
| FY2021 | $31.1M | -17.4% |
| FY2020 | $37.7M | +3.1% |
| FY2019 | $36.6M | -6.5% |
| FY2018 | $39.2M | +7.7% |
| FY2017 | $36.4M | -7.1% |
| FY2016 | $39.2M | +25.9% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026